eIF2C4 Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF2C4 monoclonal antibodies for research focused on understanding eIF2C4's role in cellular processes. eIF2C4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF2C4, also known as Argonaute 4, is a key component of the RNA-induced silencing complex (RISC) and plays a critical role in the regulation of gene expression through RNA interference. By binding to small RNA molecules, eIF2C4 facilitates the degradation of target mRNAs, thereby influencing various cellular processes such as development, differentiation, and response to stress. Understanding eIF2C4 function is vital for elucidating the mechanisms of gene regulation and its implications in diseases. Research has shown that eIF2C4 expression patterns vary across different tissue types and developmental stages. Recent studies have highlighted eIF2C4's involvement in cellular defense mechanisms and stress responses. Investigating eIF2C4's role in RNA interference pathways continues to reveal new insights into gene regulation mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of eIF2C4's role in cellular processes and disease mechanisms.